These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33377228)

  • 1. Targeting the mutant PIK3CA gene by DNA-alkylating pyrrole-imidazole polyamide in cervical cancer.
    Krishnamurthy S; Yoda H; Hiraoka K; Inoue T; Lin J; Shinozaki Y; Watanabe T; Koshikawa N; Takatori A; Nagase H
    Cancer Sci; 2021 Mar; 112(3):1141-1149. PubMed ID: 33377228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidyl inositol-3 kinase (PIK3CA) E545K mutation confers cisplatin resistance and a migratory phenotype in cervical cancer cells.
    Arjumand W; Merry CD; Wang C; Saba E; McIntyre JB; Fang S; Kornaga E; Ghatage P; Doll CM; Lees-Miller SP
    Oncotarget; 2016 Dec; 7(50):82424-82439. PubMed ID: 27489350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent activity against K562 cells by polyamide-seco-CBI conjugates targeting histone H4 genes.
    Minoshima M; Chou JC; Lefebvre S; Bando T; Shinohara K; Gottesfeld JM; Sugiyama H
    Bioorg Med Chem; 2010 Jan; 18(1):168-74. PubMed ID: 19962902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative analysis of DNA alkylation by conjugates between pyrrole-imidazole hairpin polyamides and chlorambucil or seco-CBI.
    Minoshima M; Bando T; Shinohara K; Kashiwazaki G; Nishijima S; Sugiyama H
    Bioorg Med Chem; 2010 Feb; 18(3):1236-43. PubMed ID: 20074970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The PIK3CA E542K and E545K mutations promote glycolysis and proliferation via induction of the β-catenin/SIRT3 signaling pathway in cervical cancer.
    Jiang W; He T; Liu S; Zheng Y; Xiang L; Pei X; Wang Z; Yang H
    J Hematol Oncol; 2018 Dec; 11(1):139. PubMed ID: 30547809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel gene silencer, pyrrole-imidazole polyamide targeting human lectin-like oxidized low-density lipoprotein receptor-1 gene improves endothelial cell function.
    Ueno T; Fukuda N; Tsunemi A; Yao EH; Matsuda H; Tahira K; Matsumoto T; Matsumoto K; Matsumoto Y; Nagase H; Sugiyama H; Sawamura T
    J Hypertens; 2009 Mar; 27(3):508-16. PubMed ID: 19330905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting specific gene by alkylating pyrrole-imidazole polyamides.
    Minoshima M; Chou J; Lefebvre S; Bando T; Shinohara K; Gottesfeld JM; Sugiyama H
    Nucleic Acids Symp Ser (Oxf); 2008; (52):363-4. PubMed ID: 18776404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Binding Targets of a Pyrrole-Imidazole Polyamide KR12 in the LS180 Colorectal Cancer Genome.
    Lin J; Hiraoka K; Watanabe T; Kuo T; Shinozaki Y; Takatori A; Koshikawa N; Chandran A; Otsuki J; Sugiyama H; Horton P; Nagase H
    PLoS One; 2016; 11(10):e0165581. PubMed ID: 27798693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological properties of pyrrole-imidazole polyamide conjugates.
    Minoshima M; Sasaki S; Fujimoto J; Shinohara K; Bando T; Sugiyama H
    Nucleic Acids Symp Ser (Oxf); 2007; (51):35-6. PubMed ID: 18029573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of β-Catenin Reverses Radioresistance of Cervical Cancer with the
    Jiang W; Wu Y; He T; Zhu H; Ke G; Xiang L; Yang H
    Mol Cancer Ther; 2020 Feb; 19(2):337-347. PubMed ID: 31666350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PIK3CA mutation sensitizes breast cancer cells to synergistic therapy of PI3K inhibition and AMPK activation.
    Liu S; Tang Y; Yan M; Jiang W
    Invest New Drugs; 2018 Oct; 36(5):763-772. PubMed ID: 29504069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of alkylating pyrrole-imidazole polyamide conjugates by a novel method for high-throughput sequencer.
    Kashiwazaki G; Maeda R; Kawase T; Hashiya K; Bando T; Sugiyama H
    Bioorg Med Chem; 2018 Jan; 26(1):1-7. PubMed ID: 29224995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting anaplastic lymphoma kinase (ALK) gene alterations in neuroblastoma by using alkylating pyrrole-imidazole polyamides.
    Ota Y; Yoda H; Inoue T; Watanabe T; Shinozaki Y; Takatori A; Nagase H
    PLoS One; 2021; 16(9):e0257718. PubMed ID: 34591871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer activities of alkylating pyrrole-imidazole polyamides with specific sequence recognition.
    Shinohara K; Bando T; Sugiyama H
    Anticancer Drugs; 2010 Mar; 21(3):228-42. PubMed ID: 20038830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of KRAS codon 12 mutants using a novel DNA-alkylating pyrrole-imidazole polyamide conjugate.
    Hiraoka K; Inoue T; Taylor RD; Watanabe T; Koshikawa N; Yoda H; Shinohara K; Takatori A; Sugimoto H; Maru Y; Denda T; Fujiwara K; Balmain A; Ozaki T; Bando T; Sugiyama H; Nagase H
    Nat Commun; 2015 Apr; 6():6706. PubMed ID: 25913614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcellular localization of FOXO3a as a potential biomarker of response to combined treatment with inhibitors of PI3K and autophagy in PIK3CA-mutant cancer cells.
    Kim HJ; Lee SY; Kim CY; Kim YH; Ju W; Kim SC
    Oncotarget; 2017 Jan; 8(4):6608-6622. PubMed ID: 28036259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel pyrrole-imidazole polyamide targets Aurora kinase A and suppresses tumor growth in vivo.
    Li M; Lu D; Cheng Y; Wu C; Zhang J; Shi W; Ding Z; Li Y; Cheng B; Lin X; Shao X; Li H; Fang L; Liu K; Su W
    Biochem Biophys Res Commun; 2021 Sep; 571():167-173. PubMed ID: 34330060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and anti-cancer activity of pyrrole-imidazole polyamides through target-downregulation of c-kit gene expression.
    Zhang M; Liang J; Jiang SK; Xu L; Wu YL; Awadasseid A; Zhao XY; Xiong XQ; Sugiyama H; Zhang W
    Eur J Med Chem; 2020 Dec; 207():112704. PubMed ID: 32866755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the PI3K/Akt/mTOR pathway with the pan-Akt inhibitor GDC-0068 in PIK3CA-mutant breast cancer brain metastases.
    Ippen FM; Grosch JK; Subramanian M; Kuter BM; Liederer BM; Plise EG; Mora JL; Nayyar N; Schmidt SP; Giobbie-Hurder A; Martinez-Lage M; Carter SL; Cahill DP; Wakimoto H; Brastianos PK
    Neuro Oncol; 2019 Nov; 21(11):1401-1411. PubMed ID: 31173106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular design of sequence specific DNA alkylating agents.
    Minoshima M; Bando T; Shinohara K; Sugiyama H
    Nucleic Acids Symp Ser (Oxf); 2009; (53):69-70. PubMed ID: 19749264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.